[1]
“Application of New Syncretic Antifungal Formulations against Candida Species Associated with Oral Cancer”, J Current Med Res Opinion, vol. 9, no. 03, pp. 4704–4724, Mar. 2026, doi: 10.52845/CMRO/2026/9-3-5.